Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Temsirolimus, Carboplatin, and Paclitaxel as first-line therapy for newly diagnosed stage III-IV clear cell ovarian cancer; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Clear Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-03